Clinical Trial Update: A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating polyethylene glycol (PEG) for genital herpes has been terminated; the update notes the study's focus on efficacy, safety and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• PEG (polyethylene glycol)

Snippet

Sponsor: Devirex AG | Conditions: Genital Herpes | Phase 2 | Status: TERMINATED